Condition: Liver Failure · AKI - Acute Kidney Injury · Sponsor: University Hospital, Antwerp
Study design A retrospective cohort study will be conducted to compare the efficacy and safety of citrate anticoagulation in CRRT among patients with liver failure/dysfunction and severe shock. Objectives 1. Primary Objective: To determine if the etiology of liver failure impacts the incidence of citrate-related complications in patients undergoing CRRT. 2. Secondary Objectives: To compare the efficacy of citrate anticoagulation in terms of renal recovery, filter lifespan, and patient survival between those with liver failure/dysfunction and severe shock.
This description comes directly from the study's public registry record.
Rita Jacobs, Dr. · +32 3 821 36 35 · rita.jacobs2@uza.be
Petra Vertongen · +32 3 8214404 · studies.inzo@uza.be
Always discuss trial participation with your own doctor first.
| Antwerp University Hospital | Edegem, Antwerp, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06908746